Sanofi Pasteur in Zika vaccine collaboration with US government lab

Sanofi (Euronext: SAN) is to collaborate on the co-development of a Zika vaccine candidate with the US Department of Defense’s largest biomedical research laboratory.

The French pharma major’s vaccines global business unit, Sanofi Pasteur, has announced a cooperative agreement with the Walter Reed Army Institute of Research (WRAIR).

As part of the agreement, WRAIR will transfer its Zika purified inactivated virus (ZPIV) vaccine technology to Sanofi Pasteur, opening the door for a broader collaboration with the US government.